-
Jeff Stier is a senior fellow at the National Center for Public Policy Research and directs its Risk Analysis Division.
FORBES: Cleaning Up The EWG's Dirty Dozen
-
As a result, it applies a very different set of criteria in its analysis of investment risk than it would for a private company, or even a government whose currency has no reserve status.
FORBES: S&P Downgrade Of U.S. Debt Says Nothing New
-
Value-at-risk is an analysis of the potential loss in its trading positions during a specified time frame.
FORBES: Goldman's Speed Bumps
-
GlaxoSmithKline's own analysis of its diabetes drug Avandia showed that the medicine increased the risk of heart attacks by a third.
FORBES: Magazine Article
-
With the latest technology, says Cho, the bank can measure the profitability of every branch employee and customer, mine its customer database and run sophisticated risk-management and credit-analysis programs.
FORBES: Korea's King Of Options
-
It says that its own meta-analysis of 41 Celebrex studies containing 44, 000 patients found no excess heart risk.
FORBES: More Pain For Pfizer
-
Glaxo says that its own analysis, when taken with other data, does not show a clear increased heart attack risk.
FORBES: Magazine Article